Anticoagulants

Global Industry Analysts
October 1, 2012
434 Pages - SKU: GJOB4921030
EpiCast Report: Dyslipidemia - Epidemiology Forecast to 2023
10/15/2014 | published by: GlobalData
Wind Power in Australia, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles Summary Wind Power in Australia, Market Outlook to 2025, Update 2014 - Capacity,  |  read more...
USD 3,995
Ablation Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave), Application (General & Cosmetic Surgery, Cardiovascular, Cancer, Ophthalmology, Orthopedics) - Global Forecasts to 2019
9/23/2014 | published by: MarketsandMarkets
Ablation Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave), Application (General & Cosmetic Surgery, Cardiovascular, Cancer, Ophthalmology, Orthopedics) - Global Forecasts to 2019 The global ablation technologies market is estimated to grow  |  read more...
USD 4,650
Cardiac Fibrosis - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
Cardiac Fibrosis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Cardiac Fibrosis - Pipeline Review, H2 2014’, provides an overview of the Cardiac Fibrosis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cardiac  |  read more...
USD 2,000
Acute Heart Failure - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
Acute Heart Failure - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Acute heart failure - Pipeline Review, H2 2014’, provides an overview of the Acute heart failure’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2014
9/21/2014 | published by: GlobalData
Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2014 provides data on the Ischemic Cardiomyopathy clinical trial scenario. This report provides elemental information and data  |  read more...
USD 2,500
Myocardial Ischemia Global Clinical Trials Review, H2, 2014
9/21/2014 | published by: GlobalData
Myocardial Ischemia Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Myocardial Ischemia Global Clinical Trials Review, H2, 2014 provides data on the Myocardial Ischemia clinical trial scenario. This report provides elemental information and data  |  read more...
USD 2,500
Supraventricular Tachycardia Global Clinical Trials Review, H2, 2014
9/30/2014 | published by: GlobalData
Supraventricular Tachycardia Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Supraventricular Tachycardia Global Clinical Trials Review, H2, 2014 provides data on the Supraventricular Tachycardia clinical trial scenario. This report provides elemental information and data  |  read more...
USD 2,500
Heart Attack Global Clinical Trials Review, H2, 2014
9/10/2014 | published by: GlobalData
Heart Attack Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Heart Attack Global Clinical Trials Review, H2, 2014 provides data on the Heart Attack clinical trial scenario. This report provides elemental information and data  |  read more...
USD 2,500
Heart Valve Disease Global Clinical Trials Review, H2, 2014
9/10/2014 | published by: GlobalData
Heart Valve Disease Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Heart Valve Disease Global Clinical Trials Review, H2, 2014 provides data on the Heart Valve Disease clinical trial scenario. This report provides elemental  |  read more...
USD 2,500
Hypercholesterolemia - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
Hypercholesterolemia - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Hypercholesterolemia - Pipeline Review, H2 2014’, provides an overview of the Hypercholesterolemia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hypercholesterolemia, complete with comparative  |  read more...
USD 2,000
 

SELECT A LICENSE

    PDF E-mail From Publisher  USD 4,950  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!